Replicate Bioscience Funding: $40M Raised, Series A (2021)
Replicate Bioscience is based in San Diego, California. It has raised $40M in total funding. Latest round: Series A. Backed by ATP.
Replicate Bioscience funding overview
Replicate Bioscience is based in San Diego, California. Replicate Bioscience has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2021. The round record for Replicate Bioscience runs through 2021; nothing later has been disclosed. Investors on record include ATP.
Replicate Bioscience at a glance
Total raised
$40M
Latest round
Series A
Latest round date
September 2021
Headquarters
San Diego, California
Notable investors
ATP
Frequently asked about Replicate Bioscience funding
How much has Replicate Bioscience raised?
Replicate Bioscience has raised $40M in total disclosed funding across the rounds on record.
Who has invested in Replicate Bioscience?
ATP are named among the investors backing Replicate Bioscience.
What was the latest Replicate Bioscience funding round?
The most recent disclosed round is a Series A, announced in September 2021.
Where is Replicate Bioscience based?
Replicate Bioscience is based in San Diego, California.
When did Replicate Bioscience last raise?
The last disclosed Replicate Bioscience round closed in September 2021 at Series A.
Round data for Replicate Bioscience is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in San Diego and backer lists below.
